Ventura Cannabis and Wellness Corp (OTCMKTS:CVHIF) posted substantial earnings in 2020. Its cash balance as of February 29, 2020, is $3.9 million.
In California, Ventura Cannabis possesses a type 6 license for manufacturing medical use and adult-use cannabis on 700 SQ. Ft. facility in San Francisco Bay. It also possesses a type 11 distribution license for medical use and adult-use cannabis statewide. The company also holds a significant stake in a Sacramento based delivery only AUDL (adult-use dispensary license).
Sacramento, CA-based premium delivery service – Kush Rush serves the population in the greater Sacramento and adjoining areas. Kush Rush is credited with a reputation for high quality, discrete delivery, and incredible customer service.
Kush Rush offers a variety of products at competitive rates by employing highly qualified operators. Even couriers are trained to provide reliable information about high-quality products of Venture Cannabis to the customers.
Recreational marijuana dispensary – Amberlight Cannabis based in the Richmond neighborhood provides excellent customer service in a friendly and clean environment. Customers can get personalized experience in selecting concentrates, edibles, and accessories.
Significant revenue potential
Ventura Cannabis expects to generate significant revenues when assets, including vape brands in California, are fully functional. The company also holds a retail dispensary for medical and adult-use cannabis in Portland, Oregon, to generate considerable revenues.
CEO of Ventura Cannabis, Chris Heath, said its team played a vital role in introducing high-quality cannabis assets in challenging market conditions in Oregon and California in a short period. It helped the company to maintain a strong balance sheet.
Focuses on underserved segments
Ventura Cannabis focuses on underserved and large segments in the US cannabidiol and cannabis markets to serve female professionals aged above 40 years, males, and senior citizens also those with addiction.
Ventura Cannabis provides CBD and cannabis products in a precise dose to the patients in the US to cure addiction. The market for medical marijuana and recreational marijuana in the US expects to reach $13.22 billion and $10.86 billion by 2025. Global demand for legal cannabis expects to reach $45 billion by the year 2027 from $12 billion in 2018.
Mydecine Innovations Group Inc (OTCMKTS: MYCOF) Provides an Update on Spin-Out of Cannabis Assets in the United States
Post Views: 3 Mydecine Innovations Group Inc (OTCMKTS: MYCOF) recently announced that it has both mailed and filed its management information...
Tauriga Sciences, Inc. (OTCMKTS: TAUG) Sets up a Clinical Trial to Determine the effects of Cannabidiol on Pregnant Women with a Hyperemesis Gravidarum Diagnosis.
Post Views: 6 Nausea and vomiting are very common in early pregnancy, and the victims have to ingest multiple medications....
BetterLife Pharma Inc. (OTCMKTS: BETRF) Announce Initiation Of In Vitro Studies of AP-003 Against The Delta Variant of SARS-CoV-2
Post Views: 25 Depression impacts approximately 265 million people in the world. According to WHO, it is one of the...
Ayr Wellness Inc. (OTCMKTS: AYRWF) Signs a Binding Letter of Intent to Acquire PA Natural Medicine, LLC
Post Views: 25 Curiosity about cannabis is building by the day as more expert cultivators, manufactures, budtenders, and patient consultants...
Schwazze (OTCMKTS: SHWZ) Spends $6.7 Million to Acquire the Assets of Brow 2, LLC, Located in Denver, Colorado
Post Views: 39 Innovative thinking is what will keep the next era of the cannabis industry alive. This is according...
Valens Company Inc (OTCMKTS: VLNCF) Acquires Leading, Premium Craft Licensed producer, Citizen Stash Cannabis Corp
Post Views: 109 Valens Company Inc (OTCMKTS: VLNCF), a leading manufacturer of cannabis products, announced that it entered into an...